Key result
Echocardiographic assessment of epicardial adipose tissue serves as a reliable, non-invasive marker of visceral adiposity and its associated cardiovascular and metabolic risks.
Why the study?
Visceral adipose tissue predicts unfavorable cardiovascular and metabolic risk, but existing methods to assess it have been limited.
Design
Review
Authors
Loading...
Echocardiographic epicardial fat assessment may mark visceral adiposity; leaves open prognostic value and clinical adoption pending validation.
Echocardiographic measurement of epicardial adipose tissue provides a reliable, non-invasive estimate of visceral adiposity and associated cardiometabolic risk.
Singh et al. (2020) conducted a review in Visceral adiposity. Echocardiographic assessment of epicardial adipose tissue was evaluated. Echocardiographic assessment of epicardial adipose tissue serves as a reliable, non-invasive marker of visceral adiposity and its associated cardiovascular and metabolic risks.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: